Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical Pharmacology and Therapeutics|December 23, 2006
Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjectsG W Hogeland, S Swindells, J C McNabb, et al.The Annals of Pharmacotherapy|February 24, 2001
Evaluation of outcomes in converting from intravenous ondansetron to oral granisetron: an observational studyJ S McCune, M D Oertel, D Pfeifer, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 21, 2000
Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activityS R Faucette, R L Hawke, E L Lecluyse, et al.Thrombosis and Haemostasis|May 1, 1997
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia BD Liles, C N Landen, D M Monroe, et al.Clinical Pharmacology and Therapeutics|June 1, 1994
Pharmacokinetics and pharmacodynamics of recombinant factor VIIaC M Lindley, W T Sawyer, B G Macik, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Proposal for classifying the acute emetogenicity of cancer chemotherapyP J Hesketh, M G Kris, S M Grunberg, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1993
Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I studyB G Macik, C M Lindley, J Lusher, et al.Pageof 3